90042365 - DOMPÉ X THERAPEUTICS

Information

  • Trademark
  • 90042365
  • Serial Number
    90042365
  • Filing Date
    July 08, 2020
    4 years ago
  • Transaction Date
    June 13, 2022
    2 years ago
  • Status Date
    June 13, 2022
    2 years ago
  • Published for Opposition Date
    March 16, 2021
    4 years ago
  • Location Date
    May 11, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    KERTGATE, AMY L
  • Attorney Docket Number
    363810048001
    Attorney Name
    Kristen McCallion
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
DOMPÉ X THERAPEUTICS
Case File Statements
  • GS0091: downloadable computer software for use in identifying new drugs; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phones, namely, software for use in identifying new drugs; downloadable computer software using artificial intelligence for use in identifying new drugs
  • GS0051: Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of rare ocular disorders or diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold preparations; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of rare tissue and organ transplantation-related diseases and conditions; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes
  • TR0010: The wording "DOMPE" has no meaning in a foreign language.
  • D10000: "THERAPEUTICS"
  • GS0421: software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugs; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugs; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teaching
Case File Event Statements
  • 6/13/2022 - 2 years ago
    21 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 6/13/2022 - 2 years ago
    20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 11/9/2021 - 3 years ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/5/2021 - 3 years ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/5/2021 - 3 years ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/5/2021 - 3 years ago
    16 - TEAS EXTENSION RECEIVED Type: EEXT
  • 5/11/2021 - 3 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/16/2021 - 4 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/16/2021 - 4 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/24/2021 - 4 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/11/2021 - 4 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/10/2021 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/10/2021 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/9/2021 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/6/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/20/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/20/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/20/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/16/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/6/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/11/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP